Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with anti-VEGF therapy for diabetic macular edema: A Bayesian network meta-analysis

Biomedicine and Pharmacotherapy

Volumn 97, Issue , 2018, Pages 293-299

  Wu, Ying ^a   Ai, Pu ^b   Ai, Zisheng ^a   Xu, Guotong ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Anti VEGF; Diabetes macular edema; Laser therapy; Photocoagulation; Subthreshold micropulse laser

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; ANGIOGENESIS INHIBITOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADJUVANT THERAPY; BAYESIAN LEARNING; BEST CORRECTED VISUAL ACUITY; CENTRAL MACULAR THICKNESS; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COCHRANE LIBRARY; DIABETIC MACULAR EDEMA; DRUG EFFICACY; EMBASE; HUMAN; INTERMETHOD COMPARISON; LASER COAGULATION; MEDLINE; MONOTHERAPY; NETWORK META-ANALYSIS; OUTCOME OF EDUCATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUBTHRESHOLD DIODE MICROPULSE LASER PHOTOCOAGULATION; SYSTEMATIC REVIEW; THERAPY EFFECT; ANTAGONISTS AND INHIBITORS; BAYES THEOREM; COMPARATIVE STUDY; DIABETIC RETINOPATHY; DIODE LASER; DRUG THERAPY; MACULAR EDEMA; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PROCEDURES; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; BAYES THEOREM; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; HUMANS; LASERS, SEMICONDUCTOR; LIGHT COAGULATION; MACULAR EDEMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RANIBIZUMAB; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85032257837     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.10.078     Document Type: Review

References (48)

1. International Council of Ophthalmology, ICO Guidelines for Diabetic Eye Care. 2016.
2. Neubauer, A.S., Ulbig, M.W., Laser treatment in diabetic retinopathy. Ophthalmologica 221:2 (2007), 95–102.
3. Regnier, S., Malcolm, W., Allen, F., Wright, J., Bezlyak, V., Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis (Provisional abstract). Database Abstr. Rev. Effects, 2014, e102309.
4. Diabetes: Facts and Figures. 2014, International Diabetes Federation, Brussels.
5. Anonymous Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch. Ophthalmol. (Chicago, Ill: 1960) 103 (12) (1985) 1796–1806.
6. Nguyen, Q.D., Brown, D.M., Marcus, D.M., Boyer, D.S., Patel, S., Feiner, L., Gibson, A., Sy, J., Rundle, A.C., Hopkins, J.J., et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119:4 (2012), 789–801.
7. Diabetic Retinopathy Clinical Research Network, Elman, M.J., Aiello, L.P., Beck, R.W., Bressler, N.M., Bressler, S.B., Edwards, A.R., Ferris, F.L. 3rd, Friedman, S.M., Glassman, A.R., et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117:6 (2010), 1064–1077 e1035.
8. Luttrull, J.K., Dorin, G., Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Curr. Diabetes Rev. 8:4 (2012), 274–284.
9. Luttrull, J.K., Musch, D.C., Mainster, M.A., Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br. J. Ophthalmol. 89:1 (2005), 74–80.
10. Diabetic Retinopathy Clinical Research Network, Wells, J.A., Glassman, A.R., Ayala, A.R., Jampol, L.M., Aiello, L.P., Antoszyk, A.N., Arnold-Bush, B., Baker, C.W., Bressler, N.M., et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N. Engl. J. Med. 372:13 (2015), 1193–1203.
11. Berger, A., Sheidow, T., Cruess, A.F., Arbour, J.D., Courseau, A.S., de Takacsy, F., Efficacy/safety of ranibizumab monotherapy or with laser versus laser monotherapy in DME. Can. J. Ophthalmol. J. Can. Ophtalmol. 50:3 (2015), 209–216.
12. Chen, Z.X., Fu, J.S., Song, W., Wang, C.X., Zhang, Y.L., Effect analysis of Ranibizumab with laser photocoagulation therapy for diabetic macular edema. Int. Eye Sci. 16:4 (2016), 706–708.
13. Elman, M.J., Aiello, L.P., Beck, R.W., Bressler, N.M., Bressler, S.B., Edwards, A.R., Ferris, F.L. 3rd, Friedman, S.M., Glassman, A.R., Miller, K.M., et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117:6 (2010), 1064–1077.
14. Ferraz, D., Vasquez, L., Preti, R., Motta, A., Sophie, R., Bittencourt, M., Sepah, Y., Monteiro, M., Nguyen, Q., Takahashi, W., A randomized controlled trial of panretinal photocoagulation with and without intravitreal ranibizumab in treatment-naive eyes with non-high-risk proliferative diabetic retinopathy. Retina (Philadelphia, Pa) 35 (2015), 280–287.
15. Huang, J.D., Song, Z.Y., Clinical study of grid pattern laser photocoagulation with Ranibizumab for diabetic macular edema. Int. Eye Sci. 16:3 (2016), 493–495.
16. Ishibashi, T., Li, X., Koh, A., Lai, T., Lee, F., Lee, W., Ma, Z., Ohji, M., Tan, N., Cha, S., et al. The REVEAL study: ranibizumab monotherapy or combined with laser versus laser monotherapy in asian patients with diabetic macular edema. Ophthalmology 122 (2015), 1402–1415.
17. Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G., Massin, P., Schlingemann, R., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118 (2011), 615–625.
18. Solaiman, K.A.M., Diab, M.M., Abo-Elenin, M., Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema. Retina 30:10 (2010), 1638–1645.
19. Yan, P., Qian, C., Wang, W., Dong, Y., Wan, G., Chen, Y., Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation. Therap. Clin. Risk Manage. 12 (2016), 527–533.
20. Chen, G., Li, W., Tzekov, R., Jiang, F., Mao, S., Tong, Y., Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema: a meta-analysis of randomized controlled trials (Provisional abstract). Database Abstr. Rev. Effects, 2014, e115797.
21. Liu, L., Wu, X., Geng, J., Yuan, Z., Chen, L., IVTA as adjunctive treatment to PRP and MPC for PDR and macular edema: a meta-analysis (Provisional abstract). PLoS One, 7, 2012, e44683.
22. Virgili, G., Parravano, M., Menchini, F., Evans, J.R., Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst. Rev., 10, 2014 Cd007419.
23. Chen, G., Tzekov, R., Li, W., Jiang, F., Mao, S., Tong, Y., Subthreshold micropulse diode laser versus conventional laser photocoagulation for diabetic macular edema: a meta-analysis of randomized controlled trials. Retina 36:11 (2016), 2059–2065.
24. Qiao, G., Guo, H.K., Dai, Y., Wang, X.L., Meng, Q.L., Li, H., Chen, X.H., Chen, Z.L., Sub-threshold micro-pulse diode laser treatment in diabetic macular edema: a meta-analysis of randomized controlled trials. Int. J. Ophthalmol. 9:7 (2016), 1020–1027.
25. Caldwell, D.M., Ades, A.E., Higgins, J.P., Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 331:7521 (2005), 897–900.
26. Liu, X., Zhou, X., Wang, Z., Shen, H., Comparison of intravitreal bevacizumab with macular photocoagulation for treatment of diabetic macular edema: a systematic review and meta-analysis (Provisional abstract). Database Abstr. Rev. Effects, 2014, 1048–1055.
27. Regnier, S.A., Malcolm, W.A., Efficacy comparison of anti-vegf and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis. Value Health, 18(7), 2015, A416.
28. Higgins, J.P.T., Green, S., (eds.) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011], 2011, The Cochrane Collaboration Available from www.handbook.cochrane.org.
29. Fazel, F., Bagheri, M., Golabchi, K., Jahanbani Ardakani H: Comparison of subthreshold diode laser micropulse therapy versus conventional photocoagulation laser therapy as primary treatment of diabetic macular edema. J. Curr. Ophthalmol. 28:4 (2016), 206–211.
30. Sung, L., Hayden, J., Greenberg, M.L., Koren, G., Feldman, B.M., Tomlinson, G.A., Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. J. Clin. Epidemiol. 58:3 (2005), 261–268.
31. Casson, R.J., Raymond, G., Newland, H.S., Gilhotra, J.S., Gray, T.L., Pilot randomized trial of a nanopulse retinal laser versus conventional photocoagulation for the treatment of diabetic macular oedema. Clin. Experiment. Ophthalmol. 40:6 (2012), 604–610.
32. Figueira, J., Khan, J., Nunes, S., Sivaprasad, S., Rosa, A., Abreu, J., Cunha-Vaz, J., Chong, N., Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br. J. Ophthalmol. 93 (2009), 1341–1344.
33. Laursen, M.L., Moeller, F., Sander, B., Sjoelie, A.K., Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br. J. Ophthalmol. 88:9 (2004), 1173–1179.
34. Lavinsky, D., Cardillo, J.A., Melo, L.A. Jr., Dare, A., Farah, M.E., Belfort, R. Jr., Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Investig. Ophthalmol. Vis. Sci. 52:7 (2011), 4314–4323.
35. Nguyen, Q.D., Shah, S.M., Heier, J.S., Do, D.V., Lim, J., Boyer, D., Abraham, P., Campochiaro, P.A., Primary end point (six months) results of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 116:11 (2009), 2175–2181 e2171.
36. Venkatesh, P., Ramanjulu, R., Azad, R., Vohra, R., Garg, S., Subthreshold micropulse diode laser and double frequency neodymium: YAG laser in treatment of diabetic macular edema: a prospective, randomized study using multifocal electroretinography. Photomed. Laser Surg. 29:11 (2011), 727–733.
37. Vujosevic, S., Bottega, E., Casciano, M., Pilotto, E., Convento, E., Midena, E., Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 30:6 (2010), 908–916.
38. Xie, T.Y., Guo, Q.Q., Wang, Y., Wang, Q., Chen, X.Y., Randomized, controlled clinical trial comparison of SDM laser versus argon ion laser in diabetic macular edema. Int. Eye Sci. 13:12 (2013), 2370–2372.
39. A 12-month, Two-armed, Randomized, Double-masked, Multicenter, Phase IIIb Study Assessing the Efficacy and Safety of Laser Photocoagulation as Adjunctive to Ranibizumab Intravitreal Injections vs. Laser Photocoagulation Monotherapy in Patients With Visual Impairment Due to Diabetic Macular Edema Followed by a 12 Month Follow up Period [ https://clinicaltrials.gov/ct2/show/study/NCT01131585?sect=X70156].
40. Yau, J.W., Rogers, S.L., Kawasaki, R., Lamoureux, E.L., Kowalski, J.W., Bek, T., Chen, S.J., Dekker, J.M., Fletcher, A., Grauslund, J., et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:3 (2012), 556–564.
41. Arevalo, J.F., Lasave, A.F., Wu, L., Diaz-Llopis, M., Gallego-Pinazo, R., Alezzandrini, A.A., Berrocal, M.H., Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months. Retina 33:2 (2013), 403–413.
42. Do, D., Nguyen, Q., Khwaja, A., Channa, R., Sepah, Y., Sophie, R., Hafiz, G., Campochiaro, P., Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment. JAMA Ophthalmol. 131 (2013), 139–145.
43. Nguyen, Q.D., Shah, S.M., Khwaja, A.A., Channa, R., Hatef, E., Do, D.V., Boyer, D., Heier, J.S., Abraham, P., Thach, A.B., et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 117:11 (2010), 2146–2151.
44. Jiang, H.L., Han, X.W., Zhang, S.Q., Fang, X.L., Zhao, B.J., Efficacy of intravitreal ranibizumab injection combined with macular grid photocoagulation for diabetic macular edema. Int. Eye Sci. 14:7 (2014), 1253–1256.
45. Jovanović, S., Čanadanović, V., Sabo, A., Grgić, Z., Mitrović, M., Rakić, D., Intravitreal bevacizumab injection alone or combined with macular photocoagulation compared to macular photocoagulation as primary treatment of diabetic macular edema. Vojnosanit. Pregl. 72:10 (2015), 876–882.
46. Scott, I.U., Edwards, A.R., Beck, R.W., Bressler, N.M., Chan, C.K., Elman, M.J., Friedman, S.M., Greven, C.M., Maturi, R.K., Pieramici, D.J., et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 114:10 (2007), 1860–1867.
47. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med., 6(7), 2009, e1000097.
48. Amoaku, W.M., Saker, S., Stewart, E.A., A review of therapies for diabetic macular oedema and rationale for combination therapy. Eye (London, England) 29:9 (2015), 1115–1130.